Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $504.5800 (-4.29%) ($480.5000 - $526.1000) on Mon. Aug. 24, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.53% (three month average) | RSI | 23 | Latest Price | $504.5800(-4.29%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -2.6% a day on average for past five trading days. | Weekly Trend | REGN declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(66%) XLV(54%) XBI(51%) QQQ(43%) SPY(42%) | Factors Impacting REGN price | REGN will decline at least -6.265% in a week (0% probabilities). VIXM(-17%) TLT(-9%) UUP(-4%) SHY(-4%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.265% (StdDev 12.53%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
Resistance Level | $562.7 | 5 Day Moving Average | $543.4(-7.14%) | 10 Day Moving Average | $557.84(-9.55%) | 20 Day Moving Average | $562.7(-10.33%) | To recent high | -14.8% | To recent low | 2.5% | Market Cap | $53.5b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |